Results 131 to 140 of about 91,224 (305)

Debates in Management and Treatment of CMV in Pediatric Solid Organ Transplant Recipients: A Case‐Based Discussion

open access: yesPediatric Transplantation, Volume 29, Issue 5, August 2025.
ABSTRACT The recently published 4th International Consensus Guidelines on the Management of CMV in Solid‐Organ Transplantation offers updated recommendations for CMV prevention, treatment, and monitoring in pediatric solid organ transplant (pSOT) recipients.
Kevin J. Downes   +5 more
wiley   +1 more source

Does quality of care differ when HIV patients are treated by non-specialist and specialist HIV healthcare providers in developed countries? A Systematic narrative review [PDF]

open access: yes, 2015
Copyright © 2015 by authors and Scientific Research Publishing Inc.Peer reviewedPublisher ...
Okpo, Emmanuel   +3 more
core   +1 more source

Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy

open access: yesAntimicrobial Agents and Chemotherapy, 2018
Pneumocystis jirovecii pneumonia is a life-threatening opportunistic infection in children receiving immunosuppressive chemotherapy. Without prophylaxis, up to 25% of pediatric oncology patients receiving chemotherapy will develop Pneumocystis jirovecii ...
Melissa Quinn   +13 more
semanticscholar   +1 more source

The Baby AIDS Bill [PDF]

open access: yes, 1997
Assemblywoman Mayersohn first explains the reasons behind her support for the so-called “Baby AIDS” bill; namely, that over one thousand babies in New York State tested positive for AIDS or HIV antibodies every year but medical professions were not ...
Mayersohn, Nettie
core   +2 more sources

Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients

open access: yesScientific Reports, 2018
Rituximab is associated with a higher incidence of Pneumocystis jirovecii pneumonia infection. Pneumocystis prophylaxis is advised in many immunocompromised populations treated with rituximab. However, the beneficial effect of pneumocystis prophylaxis in
K. Wei   +5 more
semanticscholar   +1 more source

A New Name for Pneumocystis from Humans and New Perspectives on the Host-Pathogen Relationship

open access: yesEmerging Infectious Diseases, 2002
The disease known as Pneumocystis carinii pneumonia (PCP) is a major cause of illness and death in persons with impaired immune systems. While the genus Pneumocystis has been known to science for nearly a century, understanding of its members remained ...
James R. Stringer   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy